Mycobacterium tuberculosis, the bacterium that causes tuberculosis, may have an Achilles’ heel: it needs a particular enzyme to survive. Inhibiting that enzyme’s function, researchers have shown, will kill the bacteria, pointing toward a design strategy for new TB drugs.